dactinomycin has been researched along with Pharyngeal Neoplasms in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (83.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kim, KH; Kwon, TK; Lee, SJ; Park, BJ; Park, SW; Roh, JL; Sung, MW | 1 |
DIPAOLO, JA; DOWD, JE; WATNE, AL | 1 |
Falucskai, L; Fehér, J; Gergely, P; Gonzalez-Cabello, R; Perl, A | 1 |
Vermund, H | 1 |
Freckman, HA | 1 |
Kagan, AR | 1 |
1 review(s) available for dactinomycin and Pharyngeal Neoplasms
Article | Year |
---|---|
Enhancement of radiation effects by chemotherapy.
Topics: Alkylating Agents; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Dactinomycin; DNA, Neoplasm; Female; Folic Acid Antagonists; Humans; Male; Methotrexate; Mouth Neoplasms; Neoplasms; Ovarian Neoplasms; Pharyngeal Neoplasms; Pyrimidines; Retinoblastoma; RNA, Neoplasm; Testicular Neoplasms; Urinary Bladder Neoplasms; Wilms Tumor | 1971 |
5 other study(ies) available for dactinomycin and Pharyngeal Neoplasms
Article | Year |
---|---|
Bile acid induces cyclo-oxygenase-2 expression in cultured human pharyngeal cells: a possible mechanism of carcinogenesis in the upper aerodigestive tract by laryngopharyngeal reflux.
Topics: Bile Acids and Salts; Cell Transformation, Neoplastic; Chenodeoxycholic Acid; Cyclooxygenase 2; Dactinomycin; Dose-Response Relationship, Drug; Enzyme Induction; Esophageal Neoplasms; Gastroesophageal Reflux; Humans; Isoenzymes; Laryngeal Neoplasms; Larynx; Membrane Proteins; Pharyngeal Neoplasms; Pharynx; Promoter Regions, Genetic; Prostaglandin-Endoperoxide Synthases; Reverse Transcriptase Polymerase Chain Reaction; Transcription, Genetic; Tumor Cells, Cultured | 2003 |
INDIVIDUALIZED CHEMOTHERAPY BY IN VITRO DRUG SELECTION.
Topics: Antineoplastic Agents; Bone Neoplasms; Dactinomycin; Female; Floxuridine; Fluorouracil; Genital Neoplasms, Female; Humans; In Vitro Techniques; Intestinal Neoplasms; Leukemia; Mechlorethamine; Melanoma; Mercaptopurine; Methotrexate; Neoplasms; Pharyngeal Neoplasms; Respiratory Tract Neoplasms; Stomach Neoplasms; Thiotepa | 1964 |
Contrasting effects of RNA and protein synthesis blocking on natural and lectin-dependent cell-mediated cytotoxicity against adherent HEp-2 cells.
Topics: Cell Adhesion; Cell Division; Cell Line; Cell Survival; Concanavalin A; Dactinomycin; Emetine; Humans; Immunity, Cellular; Lectins; Mitomycin; Mitomycins; Pharyngeal Neoplasms; Protein Biosynthesis; Puromycin; RNA | 1985 |
Results in 169 patients with cancer of the head and neck treated by intra-arterial infusion therapy.
Topics: Antineoplastic Agents; Brachial Artery; Brachiocephalic Trunk; Carcinoma, Squamous Cell; Carotid Artery, Internal; Catheterization; Cyclophosphamide; Dactinomycin; Fluorouracil; Head; Head and Neck Neoplasms; Humans; Injections, Intra-Arterial; Laryngeal Neoplasms; Melanoma; Methods; Methotrexate; Mouth Neoplasms; Neoplasms; Osteosarcoma; Paranasal Sinus Neoplasms; Pharyngeal Neoplasms; Skin Neoplasms; Skull Neoplasms; Vinblastine | 1972 |
Comments on morbidity in present-day radiotherapy.
Topics: Breast Neoplasms; Buttocks; Carcinoma, Squamous Cell; Dactinomycin; Erythema; Female; Fluorouracil; Hodgkin Disease; Humans; Laryngeal Neoplasms; Liver Cirrhosis; Methotrexate; Morbidity; Myelitis; Pharyngeal Neoplasms; Radiotherapy; Radiotherapy Dosage; Spinal Cord; Uterine Cervical Neoplasms; Xerostomia | 1971 |